The FDA has approved Mounjaro (tirzepatide) to reduce the risk of major adverse cardiovascular events, including cardiovascular death, nonfatal heart attack or nonfatal stroke, in adults with type 2 diabetes who are at high risk for these events. The approval…

Walmart has agreed to pay $50 million to resolve allegations that its pharmacies illegally filled thousands of invalid prescriptions for opioids and other controlled substances in violation of the Controlled Substances Act. The Justice Department alleged that Walmart’s compliance team…

Milwaukee-based Froedtert Memorial Lutheran Hospital sued CVS Health Aug. 20 alleging the company and its subsidiaries diverted about $18 million in 340B drug pricing savings from the hospital between 2020 and 2025. The complaint, filed in U.S. District Court for…

Indianapolis-based Eli Lilly has signed a definitive agreement to acquire Cambridge, Mass.-based Merida Biosciences, a biotechnology company aimed at advancing therapeutics for serious autoimmune and allergic diseases, for up to $2.875 billion in cash. The transaction includes an upfront payment…

For pharmacy and clinical informatics leaders, the “build-versus-buy” conundrum has become the default starting point for AI technology decisions. In medication workflows, however, that framing is incomplete. Whether an organization builds internally, buys from a vendor, or extends its EHR,…

Florida Attorney General James Uthmeier has filed a lawsuit against Prime Therapeutics LLC and Express Scripts, alleging the pharmacy benefit managers entered into an illegal horizontal price-fixing agreement that threatens access to affordable medications. The lawsuit alleges the competitors entered…

Becker’s asked pharmacy executives from hospitals and health systems, along with academic medical centers and universities across the U.S. to share what trends they deem dangerous. The 18 executives featured in this article are all speaking at Becker’s Healthcare 3rd…

The FDA has approved Lisraya (brepocitinib) tablets for adults with dermatomyositis, marking the first FDA-approved oral treatment for the rare autoimmune disease. The approval was based on a phase 3 randomized, double-blind, multicenter, placebo-controlled study involving 241 adults, according to…

The U.S. Court of Appeals for the Fifth Circuit affirmed a lower court’s ruling in favor of HHS and CMS on Aug. 26, upholding the Medicare Drug Price Negotiation Program against a constitutional challenge from PhRMA, the National Infusion Center…

The U.S. shortage of the chemotherapy drug ifosfamide has reached a “critical” stage, according to an Aug. 25 news release from the American Society of Clinical Oncology.  To address the shortage, the FDA is allowing overseas manufacturers to temporarily import…